| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.2M | +66.8% |
| R&D Expense | $132.3M | +49.0% |
| SG&A Expense | $41.9M | +14.5% |
| Operating Income | -$164.4M | -42.8% |
| Pre-tax Income | -$163.6M | -27.1% |
| Income Tax | -$4K | -116.7% |
| Net Income | -$163.6M | -27.1% |
| EPS (Basic) | -$6.08 | -33.0% |
| EPS (Diluted) | -$6.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.0M | -49.6% |
| Accounts Receivable | $6.9M | +382.8% |
| Current Assets | $406.8M | -9.0% |
| Total Assets | $452.4M | -25.9% |
| Current Liabilities | $37.4M | +43.7% |
| Stockholders' Equity | $88.1M | -66.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$120.8M | -64.1% |
| Capital Expenditures | $807K | +125.4% |
| Investing Cash Flow | $144.8M | +136.7% |
| Financing Cash Flow | -$59.3M | -234.7% |
| Free Cash Flow | -$121.6M | -64.4% |
| -33.0% |